Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jianping Chao is active.

Publication


Featured researches published by Jianping Chao.


Bioorganic & Medicinal Chemistry Letters | 2008

Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.

Younong Yu; Michael P. Dwyer; Jianping Chao; Cynthia J. Aki; Jianhua Chao; Biju Purakkattle; Diane Rindgen; Richard W. Bond; Rosemary Mayer-Ezel; James Jakway; Hongchen Qiu; R. William Hipkin; James Fossetta; Waldemar Gonsiorek; Hong Bian; Xuedong Fan; Carol Terminelli; Jay S. Fine; Daniel Lundell; J. Robert Merritt; Zhenmin He; Gaifa Lai; Minglang Wu; Arthur G. Taveras

Comprehensive SAR studies were undertaken in the 3,4-diaminocyclobut-3-ene-1,2-dione class of CXCR2/CXCR1 receptor antagonists to explore the role of the heterocycle on chemokine receptor binding affinities, functional activity, as well as oral exposure in rat. The nature of the heterocycle as well as the requisite substitution pattern around the heterocycle was shown to have a dramatic effect on the overall biological profile of this class of compounds. The furyl class, particularly the 4-halo adducts, was found to possess superior binding affinities for both the CXCR2 and CXCR1 receptors, functional activity, as well as oral exposure in rat versus other heterocyclic derivatives.


Bioorganic & Medicinal Chemistry Letters | 2009

Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.

Cynthia J. Aki; Jianping Chao; Johan A. Ferreira; Michael P. Dwyer; Younong Yu; Jianhua Chao; Robert J. Merritt; Gaifa Lai; Minglang Wu; R. William Hipkin; Xuedong Fan; Waldemar Gonsiorek; James Fosseta; Diane Rindgen; Jay S. Fine; Daniel Lundell; Arthur G. Taveras; Purakkattle J. Biju

A series of potent and orally bioavailable 3,4-diaminocyclobutenediones with various amide modifications and substitution on the left side phenyl ring were prepared and found to show significant inhibitory activities towards both CXCR2 and CXCR1 receptors.


Archive | 2003

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Arthur G. Taveras; Cynthia J. Aki; Richard W. Bond; Jianping Chao; Michael P. Dwyer; Johan A. Ferreira; Jianhua Chao; Younong Yu; John J. Baldwin; Bernd Kaiser; Ge Li; J. Robert Merritt; Purakkattle J. Biju; Kingsley H. Nelson; Laura Rokosz; James Jakway; Gaifa Lai; Minglang Wu; Evan A. Hecker; Daniel Lundell; Jay S. Fine


IDrugs : the investigational drugs journal | 1999

Farnesyl-protein transferase inhibitors

Timothy J. Guzi; Dinanath F. Rane; Alan K. Mallams; Alan B. Cooper; Ronald J. Doll; Viyyoor M. Girijavallabhan; Arthur G. Taveras; Corey Strickland; Joseph M. Kelly; Jianping Chao


Journal of Medicinal Chemistry | 2006

Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Michael P. Dwyer; Younong Yu; Jianping Chao; Cynthia J. Aki; Jianhua Chao; Purakkattle J. Biju; Viyyoor M. Girijavallabhan; Diane Rindgen; Richard W. Bond; Rosemary Mayer-Ezel; James Jakway; R. William Hipkin; James Fossetta; Waldemar Gonsiorek; Hong Bian; Xuedong Fan; Carol Terminelli; Jay S. Fine; Daniel Lundell; J. Robert Merritt; Laura L. Rokosz; Bernd Kaiser; Ge Li; Wei Wang; Tara M. Stauffer; Lynne Ozgur; Jack E. Baldwin; Arthur G. Taveras


Archive | 2002

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists

Arthur G. Taveras; Cynthia J. Aki; Richard W. Bond; Jianping Chao; Michael P. Dwyer; Johan A. Ferreira; Jonathan A. Pachter; John J. Baldwin; Bernd Kaiser; Ge Li; J. Merritt; Kingsley H. Nelson; Laura Rokosz


Bioorganic & Medicinal Chemistry Letters | 2007

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.

Jianhua Chao; Arthur G. Taveras; Jianping Chao; Cynthia J. Aki; Michael P. Dwyer; Younong Yu; Biju Purakkattle; Diane Rindgen; James Jakway; William Hipkin; James Fosetta; Xuedong Fan; Daniel Lundell; Jay S. Fine; Michael Minnicozzi; Jonathan E. Phillips; J. Robert Merritt


Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

J. Robert Merritt; Laura L. Rokosz; Kingsley H. Nelson; Bernd Kaiser; Wei Wang; Tara M. Stauffer; Lynne Ozgur; Adriane Schilling; Ge Li; John J. Baldwin; Arthur G. Taveras; Michael P. Dwyer; Jianping Chao


Archive | 2002

3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists

Arthur G. Taveras; Michael P. Dwyer; Johan A. Ferreira; Viyyoor M. Girijavallabhan; Jianping Chao; John J. Baldwin; J. Robert Merritt; Ge Li


Archive | 2003

3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists

Arthur G. Taveras; Michael P. Dwyer; Jianping Chao; John J. Baldwin; J. Robert Merritt; Ge Li; Jianhua Chao; Younong Yu

Collaboration


Dive into the Jianping Chao's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge